Eli Lilly's Mounjaro is outperforming Ozempic in clinical trials
(Newser) -
Get ready to hear a lot about a weight-loss drug called Mounjaro . Eli Lilly & Co.'s anti-obesity drug has demonstrated significant weight-loss results in clinical trials, so much so that the Wall Street Journal refers to it as the "King Kong" of such drugs. US health regulators...